Antiinflammatory and immunomodulating properties of fungal metabolites

C. Lull Noguera, H.J. Wichers, H.F.J. Savelkoul

Research output: Contribution to journalReview articleAcademicpeer-review

236 Citations (Scopus)

Abstract

We discuss current information on the ability of extracts and isolated metabolites from mushrooms to modulate immune responses. This can result in a more enhanced innate and acquired disease resistance. The major immunomodulating effects of these active substances derived from mushrooms include mitogenicity and activation of immune effector cells, such as lymphocytes, macrophages, and natural killer cells, resulting in the production of cytokines, including interleukins (ILs), tumor necrosis factor alpha (TNF)-¿, and interferon gamma (INF)-¿. In particular, the ability of selective mushroom extracts to modulate the differentiation capacity of CD4+ T cells to mature into TH1 and/or TH2 subsets will be discussed. As a consequence these extracts will have profound effects in particular diseases, like chronic autoimmune TH1-mediated or allergic TH2-mediated diseases. Immunosuppressive effects by mushroom components have also been observed. The therapeutic effects of mushrooms, such as anticancer activity, suppression of autoimmune diseases, and allergy have been associated with their immunomodulating effects. However, further studies are needed to determine the molecular mechanisms of the immunomodulating effects of mushrooms metabolites both individually and in complex mixtures, for example, extracts
Original languageEnglish
Pages (from-to)63-80
JournalMediators of Inflammation
Volume2005
Issue number2
DOIs
Publication statusPublished - 2005

Fingerprint

Agaricales
Anti-Inflammatory Agents
Disease Resistance
Interleukins
Therapeutic Uses
Immunosuppressive Agents
Complex Mixtures
Interferon-alpha
Natural Killer Cells
Autoimmune Diseases
Interferon-gamma
Hypersensitivity
Chronic Disease
Tumor Necrosis Factor-alpha
Macrophages
Lymphocytes
Cytokines
T-Lymphocytes

Keywords

  • pattern-recognition receptors
  • mushroom phellinus-linteus
  • agaricus-blazei-murill
  • natural-killer-cells
  • tumor-bearing mice
  • collagen-induced arthritis
  • protein-tyrosine kinase
  • water-soluble extract
  • cultured fruit body
  • cd4(+) t-cells

Cite this

@article{f925c38b386d4b9fbbaf537070d55ec8,
title = "Antiinflammatory and immunomodulating properties of fungal metabolites",
abstract = "We discuss current information on the ability of extracts and isolated metabolites from mushrooms to modulate immune responses. This can result in a more enhanced innate and acquired disease resistance. The major immunomodulating effects of these active substances derived from mushrooms include mitogenicity and activation of immune effector cells, such as lymphocytes, macrophages, and natural killer cells, resulting in the production of cytokines, including interleukins (ILs), tumor necrosis factor alpha (TNF)-¿, and interferon gamma (INF)-¿. In particular, the ability of selective mushroom extracts to modulate the differentiation capacity of CD4+ T cells to mature into TH1 and/or TH2 subsets will be discussed. As a consequence these extracts will have profound effects in particular diseases, like chronic autoimmune TH1-mediated or allergic TH2-mediated diseases. Immunosuppressive effects by mushroom components have also been observed. The therapeutic effects of mushrooms, such as anticancer activity, suppression of autoimmune diseases, and allergy have been associated with their immunomodulating effects. However, further studies are needed to determine the molecular mechanisms of the immunomodulating effects of mushrooms metabolites both individually and in complex mixtures, for example, extracts",
keywords = "pattern-recognition receptors, mushroom phellinus-linteus, agaricus-blazei-murill, natural-killer-cells, tumor-bearing mice, collagen-induced arthritis, protein-tyrosine kinase, water-soluble extract, cultured fruit body, cd4(+) t-cells",
author = "{Lull Noguera}, C. and H.J. Wichers and H.F.J. Savelkoul",
year = "2005",
doi = "10.1155/MI.2005.63",
language = "English",
volume = "2005",
pages = "63--80",
journal = "Mediators of Inflammation",
issn = "0962-9351",
publisher = "Hindawi Publishing Corporation",
number = "2",

}

Antiinflammatory and immunomodulating properties of fungal metabolites. / Lull Noguera, C.; Wichers, H.J.; Savelkoul, H.F.J.

In: Mediators of Inflammation, Vol. 2005, No. 2, 2005, p. 63-80.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Antiinflammatory and immunomodulating properties of fungal metabolites

AU - Lull Noguera, C.

AU - Wichers, H.J.

AU - Savelkoul, H.F.J.

PY - 2005

Y1 - 2005

N2 - We discuss current information on the ability of extracts and isolated metabolites from mushrooms to modulate immune responses. This can result in a more enhanced innate and acquired disease resistance. The major immunomodulating effects of these active substances derived from mushrooms include mitogenicity and activation of immune effector cells, such as lymphocytes, macrophages, and natural killer cells, resulting in the production of cytokines, including interleukins (ILs), tumor necrosis factor alpha (TNF)-¿, and interferon gamma (INF)-¿. In particular, the ability of selective mushroom extracts to modulate the differentiation capacity of CD4+ T cells to mature into TH1 and/or TH2 subsets will be discussed. As a consequence these extracts will have profound effects in particular diseases, like chronic autoimmune TH1-mediated or allergic TH2-mediated diseases. Immunosuppressive effects by mushroom components have also been observed. The therapeutic effects of mushrooms, such as anticancer activity, suppression of autoimmune diseases, and allergy have been associated with their immunomodulating effects. However, further studies are needed to determine the molecular mechanisms of the immunomodulating effects of mushrooms metabolites both individually and in complex mixtures, for example, extracts

AB - We discuss current information on the ability of extracts and isolated metabolites from mushrooms to modulate immune responses. This can result in a more enhanced innate and acquired disease resistance. The major immunomodulating effects of these active substances derived from mushrooms include mitogenicity and activation of immune effector cells, such as lymphocytes, macrophages, and natural killer cells, resulting in the production of cytokines, including interleukins (ILs), tumor necrosis factor alpha (TNF)-¿, and interferon gamma (INF)-¿. In particular, the ability of selective mushroom extracts to modulate the differentiation capacity of CD4+ T cells to mature into TH1 and/or TH2 subsets will be discussed. As a consequence these extracts will have profound effects in particular diseases, like chronic autoimmune TH1-mediated or allergic TH2-mediated diseases. Immunosuppressive effects by mushroom components have also been observed. The therapeutic effects of mushrooms, such as anticancer activity, suppression of autoimmune diseases, and allergy have been associated with their immunomodulating effects. However, further studies are needed to determine the molecular mechanisms of the immunomodulating effects of mushrooms metabolites both individually and in complex mixtures, for example, extracts

KW - pattern-recognition receptors

KW - mushroom phellinus-linteus

KW - agaricus-blazei-murill

KW - natural-killer-cells

KW - tumor-bearing mice

KW - collagen-induced arthritis

KW - protein-tyrosine kinase

KW - water-soluble extract

KW - cultured fruit body

KW - cd4(+) t-cells

U2 - 10.1155/MI.2005.63

DO - 10.1155/MI.2005.63

M3 - Review article

VL - 2005

SP - 63

EP - 80

JO - Mediators of Inflammation

JF - Mediators of Inflammation

SN - 0962-9351

IS - 2

ER -